News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
221,483 Results
Type
Article (4980)
Company Profile (22)
Press Release (216481)
Section
Business (82178)
Career Advice (461)
Deals (15038)
Drug Delivery (8)
Drug Development (19053)
Employer Resources (30)
FDA (3672)
Job Trends (3896)
News (120069)
Policy (7497)
Tag
Academia (290)
Alliances (14697)
Alzheimer's disease (215)
Approvals (3667)
Bankruptcy (94)
Best Places to Work (2848)
Biotechnology (24)
Breast cancer (21)
Cancer (241)
Career advice (391)
Cell therapy (55)
Clinical research (15682)
Collaboration (83)
Compensation (67)
COVID-19 (293)
C-suite (46)
Data (289)
Diabetes (24)
Diagnostics (1996)
Earnings (39984)
Employer resources (31)
Events (36954)
Executive appointments (135)
FDA (3782)
Funding (93)
Gene therapy (25)
GLP-1 (97)
Government (406)
Healthcare (4998)
Infectious disease (304)
Inflammatory bowel disease (22)
Interviews (53)
IPO (7736)
Job creations (1120)
Job search strategy (360)
Layoffs (95)
Legal (2322)
Lung cancer (26)
Manufacturing (28)
Medical device (3816)
Medtech (3817)
Mergers & acquisitions (7343)
Metabolic disorders (74)
Neuroscience (260)
NextGen Class of 2024 (1671)
Non-profit (725)
Northern California (530)
Obesity (36)
Opinion (28)
People (24166)
Phase I (4674)
Phase II (6817)
Phase III (5410)
Pipeline (263)
Postmarket research (625)
Preclinical (1832)
Press Release (66)
Radiopharmaceuticals (103)
Rare diseases (38)
Real estate (1868)
Regulatory (4980)
Research institute (298)
Resumes & cover letters (68)
Southern California (402)
Startups (1006)
United States (4225)
Vaccines (25)
Date
Last 7 days (166)
Last 30 days (1185)
Last 365 days (11138)
2024 (10327)
2023 (13193)
2022 (18660)
2021 (19679)
2020 (18239)
2019 (13205)
2018 (10206)
2017 (10001)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (182)
Arizona (49)
Asia (11285)
Australia (1558)
California (1080)
Canada (456)
China (30)
Colorado (42)
Connecticut (56)
Europe (23971)
Florida (139)
Georgia (22)
Idaho (23)
Illinois (75)
Indiana (35)
Japan (30)
Kansas (23)
Maine (34)
Maryland (138)
Massachusetts (898)
Michigan (60)
Minnesota (98)
New Jersey (336)
New York (302)
North Carolina (239)
Northern California (530)
Ohio (36)
Pennsylvania (227)
South America (273)
Southern California (402)
Texas (128)
Utah (31)
Washington State (98)
221,483 Results for "immunobiochem corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates
ImmunoBiochem Corporation announced a multi-target license and option agreement with ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates, to advance novel, first-in-class ADCs.
July 24, 2023
·
4 min read
Genetown
ImmunoGen Announces Multi-Target License and Option Agreement with ImmunoBiochem to Develop Next-Generation Antibody-Drug Conjugates
ImmunoGen, Inc. announced a multi-target license and option agreement to research novel, first-in-class ADCs with ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel biological therapeutics.
July 24, 2023
·
5 min read
Business
ImmunoGen Inks Cancer ADC Partnership with ImmunoBiochem
The license and option deal, for an undisclosed amount, seeks to develop potentially first-in-class antibody-drug conjugate candidates against different oncology targets.
July 25, 2023
·
2 min read
·
Tristan Manalac
Press Releases
Shimadzu Invests in Sepragen Corporation
November 20, 2024
·
2 min read
Deals
Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.
May 28, 2024
·
9 min read
Press Releases
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
November 12, 2024
·
15 min read
Business
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”) today announced financial results and recent corporate highlights for the first quarter ended March 31, 2024.
May 13, 2024
·
15 min read
Pharm Country
Quest Diagnostics Releases 2023 Corporate Responsibility Report
Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.
June 27, 2024
·
3 min read
Biotech Bay
Aridis Provides Corporate Update - June 24, 2024
Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.
June 24, 2024
·
8 min read
Press Releases
Greenwich LifeSciences Provides Update on Corporate Events
November 18, 2024
·
5 min read
1 of 22,149
Next